' '̶ Ҹ. ӵ ̰, ġϸ İ ̴. . ϵ Ÿ ġ ֿ ̵ ְ, 赵 ִ. ڸ ִٸ, Ҹ ϰ ֱ ˻縦 ϴ ʿϴ. ˷ ִ 缱 ̴. ֺ 缱 ġḦ ߺ 赵 ϸ, Ư ̰ 赵 ϴ ˷. µ ߿ ϳ. , ڿü 氣, ΰ ġ Ÿ. ٿ '', 赵 δ 1, ϼ ϴпб ± 2001~2023 м ǥ 22 ȣƮ Ÿм , 輺 ϰ Ÿٰ . 10 ̴ Ǿ, ǥ Ը ü ٴ ־. ̿ ֱٱ ǥ Ÿм ߴ. , ü 33% Ÿ. ̴ , , α Ÿм ϰ . ± ̴ ִٰ Ѵ. 켱, ڱȣ(TSH) ġ ڱν ִ. ν ν ʷϰ ν缺-1(IGF-1) ü ڱ ν ִ. 1 ڴ εþ 츣 ī̶ (Urfa Khairatun HISAN)̸, SCIE м ' (Nutrition and Cancer)' ¶ ǵǾ. 氣, ڿü 氣 ִ. ϻZ к ̿ 20~39 310 氣 мߴ. , 氣 氣 30 ̻ 60 ̸ ߺ 1.36, 1.44 Ҵ. 氣 60 ̻ 쿡 ߺ 1.71, 1.81 мƴ. "ڿü 氣 ִ ν , , ڱ ȣ ġ Ѵ" ߴ. ش 'ӻк (Journal of Clinical Endocrinology and Metabolism)' ƴ. Ѱ ڸ ߰ ģٰ ִ. ̱ȸ ߰ϴ м '(Cancer)' ¶ǿ , ü뿡 ִ Ȯϱ 50~71 ̱ 46 мߴ. м , ߰ ̵ ̵ 55% Ҵ. Ư ε巯 Ÿµ 81% ݸ, 29% ƴ. "߰ ȣ к ϰ ο ü ɷ ߷ ִ" ϸ鼭, "̹ ִ , ߰ ϴ ̶ Ȯ " ߴ.
|